分级(工程)
医学
肾细胞癌
病理
清除单元格
前列腺癌
嫌色细胞
放射科
内科学
癌症
生物
生态学
作者
Brett Delahunt,Lars Egevad,Hemamali Samaratunga,Guido Martignoni,John N Nacey,John R. Srigley
摘要
Grading is an important prognostic parameter for prostate adenocarcinoma and renal cell carcinoma ( RCC ); however, the most frequently used classifications fail to account for advances in our understanding of the diagnostic features, classification and/or behaviour of these tumours. In 2005 and 2014, the International Society of Urological Pathology ( ISUP ) proposed changes to Gleason scoring with the adoption of the ISUP grading for prostate cancer in 2014 (grade 1, score 3 + 3; grade 2, score 3 + 4; grade 3, score 4 + 3; grade 4, score 8; grade 5, score 9–10). Internationally the Fuhrman grading system is widely employed despite criticisms related to its application, validity, and reproducibility. In 2012, the ISUP established a grading system for RCC (grade 1, the nucleolus is not seen or is inconspicuous and basophilic at ×400 magnification; grade 2, nucleoli are eosinophilic and clearly visible at ×400 magnification; grade 3, nucleoli are clearly visible at ×100 magnification; grade 4, tumours show extreme pleomorphism or rhabdoid and/or sarcomatoid morphology). This grading has been validated for clear cell RCC and papillary RCC . It was further recommended that chromophobe RCC not be graded. For other morphotypes of RCC , ISUP grading has not been validated as a prognostic parameter, but can be used for descriptive purposes.
科研通智能强力驱动
Strongly Powered by AbleSci AI